Sun Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of ₹10,931 Crore, up from ₹9,447 Crore year on year depicting a growth
Sun Pharmaceuticals Ltd Q4FY23 results out, revenue grows by 16%

Sun Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of ₹10,931 Crore, up from ₹9,447 Crore year on year depicting a growth
Suven Pharma is in the business of Contract development & manufacturing organisation (CDMO), catering to the needs of global Pharma Industry. SPL
Key highlights from Sequent Scientific Limited (SEQUENT) Q4 FY23 Earnings Concall Q&A Highlights: [00:14:02] Vishwas asked about the utilization of the API
Key highlights from Glenmark Pharmaceuticals Limited (GLENMARK) Q4 FY23 Earnings Concall Q&A Highlights: [00:27:19] Tushar Manudhane at Motilal Oswal asked about the
Alkem Laboratories Ltd (NSE:ALKEM) Q4 FY23 Earnings Concall dated May. 19, 2023. Corporate Participants: Amit Khandelia -- Associate Vice President, Finance Sandeep Singh -- Managing Director
Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q4 FY23 Earnings Concall Q&A Highlights: [00:11:30] Tushar Manudhane from Motilal Oswal asked if backward
Sun Pharma Advanced Research Company Ltd is engaged in the business of research and development (R&D) of pharmaceutical products. The company is
Gland Pharma Limited (NSE:GLAND) Q4 FY23 Earnings Concall dated May. 18, 2023. Corporate Participants: Sumanta Bajpayee -- Vice President, Finance and Investor Relations Srinivas
Zydus Lifesciences Ltd (NSE: ZYDUSLIFE) Q4 FY23 earnings concall dated May. 18, 2023 Corporate Participants: Ganesh Nayak -- Executive Director Sharvil Patel -- Managing Director Nitin
In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble
Shalby Ltd reported Total revenue for Q4 FY23 of ₹199 Crore, up from ₹163 Crore year on year depicting a growth of
Shalby Ltd is engaged in healthcare delivery space in India. It operates a chain of multi-specialty hospitals across India. The business of
Metropolis Healthcare Limited (NSE: METROPOLIS) Q4 FY23 earnings concall dated May. 16, 2023 Corporate Participants: Ameera Shah -- Managing Director Surendran Chemmenkotil -- Chief Executive Officer
Zydus Wellness Ltd (NSE: ZYDUSWELL) Q4 FY23 earnings concall dated May. 17, 2023 Corporate Participants: Tarun Arora -- Chief Executive Officer and Whole Time
Max Healthcare Institute Ltd (NSE: MAXHEALTH) Q4 FY23 earnings concall dated May. 17, 2023 Corporate Participants: Abhay Soi -- Chairman and Managing Director Yogesh
P&G Health Ltd. manufactures and sells medications and chemicals. Financial Results: Procter & Gamble Health Limited reported Total Income for Q4FY23 of
Granules India Ltd (NSE:GRANULES) Q4 FY23 Earnings Concall dated May. 16, 2023. Corporate Participants: Irfan Raeen -- Investor Relations Krishna Prasad -- Chairman and Managing Director
Max Healthcare Institute’s revenue in Q4FY23 rose 26% to ₹ 1,637 crores. Consolidated Profit After Tax came at ₹ 320 crores in
Pharmaceutical product manufacture, marketing, trade, and export are all activities of Pfizer Ltd. It produces goods in-house and also works with several
Themis Medicare Ltd (NSE: THEMISMED) Q4 FY23 earnings concall dated May. 15, 2023 Corporate Participants: Sachin Patel -- Managing Director and Chief Executive Officer
Rainbow Children's Medicare Ltd (NSE: RAINBOW) Q4 FY23 earnings concall dated May. 15, 2023 Corporate Participants: Ramesh Kancharla -- Chairman and Managing Director Sanjeev